HIGHLIGHTS
- who: Wenjing Gu from the Department of Reproductive Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan have published the Article: Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer, in the Journal: (JOURNAL)
- what: The authors aimed to assess the effects of PRL on EC cells during combined treatment with progestin and metformin. The authors aimed to investigate PRL levels before and during medroxyprogesterone 17-acetate (MPA; a progestin) treatment. The authors demonstrated that the inhibition of PRL production and its action may . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.